{"id":87762,"date":"2023-03-30T00:00:00","date_gmt":"2023-03-30T00:00:00","guid":{"rendered":"http:\/\/kuwaitnewsgazette.com\/?guid=c97b0cb1f4260d63a6c5d192636a3b2f"},"modified":"2023-03-30T00:00:00","modified_gmt":"2023-03-30T00:00:00","slug":"eu-agency-recommends-approval-of-bimervax-as-a-covid-19-booster-vaccine","status":"publish","type":"post","link":"https:\/\/kuwaitnewsgazette.com\/eu-agency-recommends-approval-of-bimervax-as-a-covid-19-booster-vaccine\/","title":{"rendered":"EU agency recommends approval of Bimervax as a COVID-19 booster vaccine"},"content":{"rendered":"
The European Medicines Agency (EMA) Thursday recommended authorising the COVID-19 vaccine Bimervax (previously COVID-19 Vaccine HIPRA) as a booster in people aged 16 years and above who have been vaccinated with an mRNA COVID-19 vaccine.<\/p>\n<\/p>\n
Bimervax, developed by HIPRA Human Health, a multinational company based in Spain, contains a protein produced in the laboratory that consists of part of the SARS-CoV-2 spike protein from the Alpha and Beta virus variants, it said in a press release.<\/p>\n<\/p>\n
EMA concluded that a booster dose of Bimervax is expected to be at least as effective as Comirnaty at restoring protection against COVID-19 in people aged 16 years and older It added that the benefits of Bimervax outweigh its risks and recommended granting a standard marketing authorisation in the EU.<\/p>\n<\/p>\n
Source: Kuwait News Agency<\/p><\/p>\n","protected":false},"excerpt":{"rendered":"
The European Medicines Agency (EMA) Thursday recommended authorising the COVID-19 vaccine Bimervax (previously COVID-19 Vaccine HIPRA) as a booster in people aged 16 years and above who have been vaccinated with an mRNA COVID-19 vaccine.Bimervax, devel…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"yoast_head":"\n